Scholars Central

Conference abstract

Expanding BCS-based biowaivers

Authors: Lisa Murray

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

R ecord numbers of patent expirations, unprecedented expansion of the global generics market, and mounting pressure from government and customers for low-cost drugs, contribute to the need for reliable, economical, and expeditious test systems for supporting BCS-based biowaivers. And yet, this pathway remains underutilized by the generic industry. This session will review progress which has been made in BCS permeability classification techniques, including identification of increasingly accurate internal standards and optimized pH conditions. Current limitations will also be explored, including passive transport requirements and solubility conditions. Opportunities for applying updated science and ultimately expanding the utility of BCS biowaivers will be discussed.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Journal of Bioequivalence & Bioavailability.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Bioequivalence & Bioavailability
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Lisa Murray”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels